bucindolol has been researched along with prazosin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Marwood, JF; Stokes, GS | 2 |
3 other study(ies) available for bucindolol and prazosin
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Bucindolol has serotonin and alpha-adrenoceptor blocking properties.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; In Vitro Techniques; Ketanserin; Male; Phenylephrine; Piperidines; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Regional Blood Flow; Serotonin Antagonists | 1985 |
Studies on the vasodilator actions of bucindolol in the rat.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Vagotomy; Vasodilation | 1986 |